Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Qiagen (QGEN) Research & Development (2016 - 2025)

Historic Research & Development for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to $47.2 million.

  • Qiagen's Research & Development fell 281.86% to $47.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $187.5 million, marking a year-over-year decrease of 308.95%. This contributed to the annual value of $187.5 million for FY2025, which is 308.95% down from last year.
  • As of Q4 2025, Qiagen's Research & Development stood at $47.2 million, which was down 281.86% from $48.7 million recorded in Q3 2025.
  • In the past 5 years, Qiagen's Research & Development registered a high of $54.7 million during Q1 2023, and its lowest value of $42.1 million during Q4 2021.
  • Over the past 5 years, Qiagen's median Research & Development value was $47.8 million (recorded in 2023), while the average stood at $47.9 million.
  • As far as peak fluctuations go, Qiagen's Research & Development surged by 3625.08% in 2021, and later crashed by 1470.79% in 2025.
  • Over the past 5 years, Qiagen's Research & Development (Quarter) stood at $42.1 million in 2021, then increased by 6.19% to $44.7 million in 2022, then grew by 2.79% to $46.0 million in 2023, then grew by 5.74% to $48.6 million in 2024, then decreased by 2.82% to $47.2 million in 2025.
  • Its last three reported values are $47.2 million in Q4 2025, $48.7 million for Q3 2025, and $47.8 million during Q2 2025.